年薪142万，人福医药副总经理辞职

Group 1 - Company announced that Vice President Zheng Chenggang resigned due to personal reasons, effective upon delivery of his resignation report to the board [1][8] - Zheng Chenggang will continue to serve as a director in the company's subsidiary [1][8] - Zheng Chenggang's annual salary before tax was reported to be 1.4272 million yuan [6][11] Group 2 - The company, Renfu Pharmaceutical, focuses on anesthetics and neurological medications, being a leading player in this niche market, often referred to as the "King of Anesthesia Drugs" in China [6][12] - Core products include fentanyl, which is strictly regulated in China, with only three companies approved to produce fentanyl raw materials and five for its formulations, with Renfu being one of them [7][12] - The company faced regulatory scrutiny, with the Hubei Securities Regulatory Bureau proposing a fine of 36.7 million yuan due to issues related to undisclosed non-operating fund occupation and other violations [6][11]